muraymycins (Wyeth)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemuraymycins (Wyeth)
Drug Alias Namemuraymycins (Wyeth-Ayerst Research)muraymycin A1WAY-171433
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Research
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A